{"transactions":[{"id":755725,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:05:24.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":12837,"price":69.74,"value":895252.38,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2565489,"source":{"system":"sec-edgar","filing":"0001193125-26-253459","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526253459/ownership.xml","form_type":"4"}},{"id":755724,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:05:24.000Z","date":"2026-05-29","kind":"gift","planned":true,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Katherine A. Blenko 2026 Grantor Retained Annuity Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Transfer of shares without consideration to the Katherine A. Blenko 2026 Grantor Retained Annuity Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares are held by Katherine A. Blenko 2026 Grantor Retained Annuity Trust, of which the spouse of the Reporting Person is the trustee."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001193125-26-253459","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526253459/ownership.xml","form_type":"4"}},{"id":755723,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:05:24.000Z","date":"2026-05-29","kind":"gift","planned":true,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Joseph K. Belanoff 2026 Grantor Retained Annuity Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transfer of shares without consideration to the Joseph K. Belanoff 2026 Grantor Retained Annuity Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held by Joseph K. Belanoff 2026 Grantor Retained Annuity Trust, of which the Reporting Person is the trustee."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001193125-26-253459","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526253459/ownership.xml","form_type":"4"}},{"id":755722,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:05:24.000Z","date":"2026-05-29","kind":"gift","planned":true,"acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2578326,"source":{"system":"sec-edgar","filing":"0001193125-26-253459","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526253459/ownership.xml","form_type":"4"}},{"id":792617,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-05T20:30:11.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":50.0965,"value":2003860.0,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $50.00 to $50.35 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2878326,"source":{"system":"sec-edgar","filing":"0001193125-26-206540","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526206540/ownership.xml","form_type":"4"}},{"id":826738,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-27T20:27:54.000Z","date":"2026-03-25","kind":"sale","planned":true,"acquired":false,"shares":26198,"price":50.0735,"value":1311825.553,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $50.00 to $50.32 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2918326,"source":{"system":"sec-edgar","filing":"0001193125-26-129143","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526129143/ownership.xml","form_type":"4"}},{"id":870159,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-03T23:17:15.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":460000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercise ratably in equal installments on each monthly anniversary of February 27, 2026 over a four-year period subject to the Reporting Person's continued service through each vesting date."}],"balance_after":460000,"derivative":{"exercise_price":35.7,"expiration_date":"2036-02-27","underlying":"Common Stock","underlying_shares":460000},"source":{"system":"sec-edgar","filing":"0001193125-26-089023","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526089023/ownership.xml","form_type":"4"}},{"id":958840,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-12-29T22:24:48.000Z","date":"2025-12-24","kind":"exercise","planned":false,"acquired":false,"shares":550000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.88,"expiration_date":"2026-02-26","underlying":"Common Stock","underlying_shares":550000},"source":{"system":"sec-edgar","filing":"0001193125-25-335538","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525335538/ownership.xml","form_type":"4"}},{"id":958839,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-29T22:24:48.000Z","date":"2025-12-24","kind":"other","planned":false,"acquired":true,"shares":243154,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transfer of shares without consideration to the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2944524,"source":{"system":"sec-edgar","filing":"0001193125-25-335538","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525335538/ownership.xml","form_type":"4"}},{"id":958838,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-29T22:24:48.000Z","date":"2025-12-24","kind":"gift","planned":false,"acquired":false,"shares":243154,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-335538","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525335538/ownership.xml","form_type":"4"}},{"id":958837,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-29T22:24:48.000Z","date":"2025-12-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":306846,"price":83.59,"value":25649257.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability from a net (cashless) exercise of options."}],"balance_after":243154,"source":{"system":"sec-edgar","filing":"0001193125-25-335538","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525335538/ownership.xml","form_type":"4"}},{"id":958836,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-29T22:24:48.000Z","date":"2025-12-24","kind":"exercise","planned":false,"acquired":true,"shares":550000,"price":3.88,"value":2134000.0,"ownership":{"direct":true},"balance_after":550000,"source":{"system":"sec-edgar","filing":"0001193125-25-335538","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525335538/ownership.xml","form_type":"4"}},{"id":982388,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-04T01:14:37.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":79.7699,"value":3190796.0,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $79.65 to $79.97 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2701370,"source":{"system":"sec-edgar","filing":"0001193125-25-307204","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525307204/ownership.xml","form_type":"4"}},{"id":1007186,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-06T00:57:57.000Z","date":"2025-11-05","kind":"sale","planned":true,"acquired":false,"shares":3590,"price":75.9777,"value":272759.943,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $75.725 to $76.28 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2741370,"source":{"system":"sec-edgar","filing":"0001193125-25-267545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525267545/ownership.xml","form_type":"4"}},{"id":1007185,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-06T00:57:57.000Z","date":"2025-11-05","kind":"sale","planned":true,"acquired":false,"shares":10837,"price":75.1372,"value":814261.8364,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $74.72 to $75.71 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2744960,"source":{"system":"sec-edgar","filing":"0001193125-25-267545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525267545/ownership.xml","form_type":"4"}},{"id":1007184,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-06T00:57:57.000Z","date":"2025-11-05","kind":"sale","planned":true,"acquired":false,"shares":14355,"price":74.196,"value":1065083.58,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.72 to $74.70 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2755797,"source":{"system":"sec-edgar","filing":"0001193125-25-267545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525267545/ownership.xml","form_type":"4"}},{"id":1007183,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-06T00:57:57.000Z","date":"2025-11-03","kind":"sale","planned":true,"acquired":false,"shares":11218,"price":74.0786,"value":831013.7348,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.74 to $74.26 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2770152,"source":{"system":"sec-edgar","filing":"0001193125-25-267545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525267545/ownership.xml","form_type":"4"}},{"id":1025444,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-03T21:24:13.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":3194,"price":85.6662,"value":273617.8428,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $85.63 to $85.785 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2781370,"source":{"system":"sec-edgar","filing":"0001193125-25-230467","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525230467/ownership.xml","form_type":"4"}},{"id":1025443,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-03T21:24:13.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":31190,"price":85.164,"value":2656265.16,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $84.5875 to $85.575 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2784564,"source":{"system":"sec-edgar","filing":"0001193125-25-230467","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525230467/ownership.xml","form_type":"4"}},{"id":1025442,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-03T21:24:13.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":5616,"price":84.2895,"value":473369.832,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $83.58 to $84.53 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2815754,"source":{"system":"sec-edgar","filing":"0001193125-25-230467","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525230467/ownership.xml","form_type":"4"}},{"id":1048521,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-04T23:54:04.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":700,"price":71.0107,"value":49707.49,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $70.97 to $71.085 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2821370,"source":{"system":"sec-edgar","filing":"0001193125-25-196313","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525196313/ownership.xml","form_type":"4"}},{"id":1048520,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-04T23:54:04.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":39300,"price":70.5172,"value":2771325.96,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $69.97 to $70.96 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2822070,"source":{"system":"sec-edgar","filing":"0001193125-25-196313","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312525196313/ownership.xml","form_type":"4"}},{"id":1075262,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-05T22:51:26.000Z","date":"2025-08-01","kind":"sale","planned":true,"acquired":false,"shares":5446,"price":69.6483,"value":379304.6418,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $69.4412 to $69.77 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2861370,"source":{"system":"sec-edgar","filing":"0000950170-25-103323","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025103323/ownership.xml","form_type":"4"}},{"id":1075261,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-05T22:51:26.000Z","date":"2025-08-01","kind":"sale","planned":true,"acquired":false,"shares":17809,"price":68.8689,"value":1226486.2401,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $68.43 to $69.42 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2866816,"source":{"system":"sec-edgar","filing":"0000950170-25-103323","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025103323/ownership.xml","form_type":"4"}},{"id":1075260,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-05T22:51:26.000Z","date":"2025-08-01","kind":"sale","planned":true,"acquired":false,"shares":16745,"price":67.8063,"value":1135416.4935,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $67.42 to $68.33 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2884625,"source":{"system":"sec-edgar","filing":"0000950170-25-103323","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025103323/ownership.xml","form_type":"4"}},{"id":1084239,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-21T23:11:17.000Z","date":"2025-07-17","kind":"sale","planned":true,"acquired":false,"shares":615,"price":73.6873,"value":45317.6895,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.655 to $73.74 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2901370,"source":{"system":"sec-edgar","filing":"0000950170-25-097372","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025097372/ownership.xml","form_type":"4"}},{"id":1123594,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-05T00:41:08.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":8408,"price":85.0116,"value":714777.5328,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $85.00 to $85.31 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2901985,"source":{"system":"sec-edgar","filing":"0000950170-25-081939","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081939/ownership.xml","form_type":"4"}},{"id":1123593,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-05T00:41:08.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":12959,"price":84.5715,"value":1095962.0685,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $83.975 to $84.94 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2910393,"source":{"system":"sec-edgar","filing":"0000950170-25-081939","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081939/ownership.xml","form_type":"4"}},{"id":1123592,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-05T00:41:08.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":4631,"price":83.4643,"value":386523.1733,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $82.96 to $83.95 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2923352,"source":{"system":"sec-edgar","filing":"0000950170-25-081939","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081939/ownership.xml","form_type":"4"}},{"id":1123591,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-05T00:41:08.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":1263,"price":82.2634,"value":103898.6742,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $81.935 to $82.80 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2927983,"source":{"system":"sec-edgar","filing":"0000950170-25-081939","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081939/ownership.xml","form_type":"4"}},{"id":1123590,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-05T00:41:08.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":1820,"price":81.3255,"value":148012.41,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $80.92 to $81.78 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2929246,"source":{"system":"sec-edgar","filing":"0000950170-25-081939","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081939/ownership.xml","form_type":"4"}},{"id":1123589,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-05T00:41:08.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":2988,"price":80.3017,"value":239941.4796,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $79.90 to $80.8925 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2931066,"source":{"system":"sec-edgar","filing":"0000950170-25-081939","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081939/ownership.xml","form_type":"4"}},{"id":1123588,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-05T00:41:08.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":3050,"price":79.4823,"value":242421.015,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $78.88 to $79.865 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2934054,"source":{"system":"sec-edgar","filing":"0000950170-25-081939","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081939/ownership.xml","form_type":"4"}},{"id":1123587,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-05T00:41:08.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":4881,"price":78.4211,"value":382773.3891,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $77.84 to $78.83 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2937104,"source":{"system":"sec-edgar","filing":"0000950170-25-081939","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025081939/ownership.xml","form_type":"4"}},{"id":1159904,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-06T00:28:36.000Z","date":"2025-05-02","kind":"sale","planned":true,"acquired":false,"shares":21520,"price":73.2238,"value":1575776.176,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.00 to $73.65 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2941985,"source":{"system":"sec-edgar","filing":"0000950170-25-063831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025063831/ownership.xml","form_type":"4"}},{"id":1159903,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-06T00:28:36.000Z","date":"2025-05-02","kind":"sale","planned":true,"acquired":false,"shares":18480,"price":72.5187,"value":1340145.576,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $72.13 to $72.99 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2963505,"source":{"system":"sec-edgar","filing":"0000950170-25-063831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025063831/ownership.xml","form_type":"4"}},{"id":1184514,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-03T00:01:10.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":350,"price":114.71,"value":40148.5,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2981985,"source":{"system":"sec-edgar","filing":"0000950170-25-049790","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025049790/ownership.xml","form_type":"4"}},{"id":1184513,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-03T00:01:10.000Z","date":"2025-03-31","kind":"sale","planned":true,"acquired":false,"shares":35102,"price":94.72,"value":3324861.44,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2982335,"source":{"system":"sec-edgar","filing":"0000950170-25-049790","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025049790/ownership.xml","form_type":"4"}},{"id":1191478,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-26T21:07:53.000Z","date":"2025-03-24","kind":"sale","planned":true,"acquired":false,"shares":1974,"price":60.8329,"value":120084.1446,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $60.83 to $60.93 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":3017437,"source":{"system":"sec-edgar","filing":"0000950170-25-045433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025045433/ownership.xml","form_type":"4"}},{"id":1231341,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-03-05T00:44:51.000Z","date":"2025-02-28","kind":"grant","planned":true,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercise ratably in equal installments on each monthly anniversary of February 28, 2025 over a four-year period subject to the Reporting Person's continued service through each vesting date."}],"balance_after":350000,"derivative":{"exercise_price":60.58,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0000950170-25-032740","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025032740/ownership.xml","form_type":"4"}},{"id":1231340,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-05T00:44:51.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":2924,"price":60.909,"value":178097.916,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $60.83 to $61.045 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":3019411,"source":{"system":"sec-edgar","filing":"0000950170-25-032740","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025032740/ownership.xml","form_type":"4"}},{"id":1268078,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-14T21:40:36.000Z","date":"2024-07-31","kind":"other","planned":false,"acquired":true,"shares":190417,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer of shares without consideration to the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Due to an administrative error, prior reporting of the name of this trust has been corrected. The exact name of the trust, \"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02\" was mistakenly identified as the \"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02\"."}],"balance_after":3022335,"source":{"system":"sec-edgar","filing":"0000950170-25-021329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025021329/ownership.xml","form_type":"5"}},{"id":1268077,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-14T21:40:36.000Z","date":"2024-07-31","kind":"gift","planned":false,"acquired":false,"shares":190417,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-021329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025021329/ownership.xml","form_type":"5"}},{"id":1268076,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-14T21:40:36.000Z","date":"2022-07-06","kind":"other","planned":false,"acquired":true,"shares":348811,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer of shares without consideration to the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Due to an administrative error, prior reporting of the name of this trust has been corrected. The exact name of the trust, \"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02\" was mistakenly identified as the \"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02\"."}],"balance_after":2831918,"source":{"system":"sec-edgar","filing":"0000950170-25-021329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025021329/ownership.xml","form_type":"5"}},{"id":1268075,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-14T21:40:36.000Z","date":"2022-07-06","kind":"gift","planned":false,"acquired":false,"shares":348811,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":190417,"source":{"system":"sec-edgar","filing":"0000950170-25-021329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025021329/ownership.xml","form_type":"5"}},{"id":1443408,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-08-02T20:42:32.000Z","date":"2024-07-31","kind":"exercise","planned":false,"acquired":false,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.29,"expiration_date":"2025-02-18","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0000950170-24-090052","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024090052/ownership.xml","form_type":"4"}},{"id":1443407,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-02T20:42:32.000Z","date":"2024-07-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":259583,"price":38.67,"value":10038074.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on July 31, 2024. The options subject to the net exercise were to expire on February 18, 2025."}],"balance_after":539228,"source":{"system":"sec-edgar","filing":"0000950170-24-090052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024090052/ownership.xml","form_type":"4"}},{"id":1443406,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-02T20:42:32.000Z","date":"2024-07-31","kind":"exercise","planned":false,"acquired":true,"shares":450000,"price":3.29,"value":1480500.0,"ownership":{"direct":true},"balance_after":798811,"source":{"system":"sec-edgar","filing":"0000950170-24-090052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024090052/ownership.xml","form_type":"4"}},{"id":1647150,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-02-14T01:25:49.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of February 9, 2024 over a four-year period."}],"balance_after":500000,"derivative":{"exercise_price":23.01,"expiration_date":"2034-02-09","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000950170-24-014879","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024014879/ownership.xml","form_type":"4"}},{"id":2014087,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-02-16T00:59:02.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of February 13, 2023 over a four-year period."}],"balance_after":500000,"derivative":{"exercise_price":23.06,"expiration_date":"2033-02-12","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000899243-23-005173","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924323005173/doc4.xml","form_type":"4"}},{"id":2210180,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-07-08T21:20:19.000Z","date":"2022-07-06","kind":"exercise","acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.08,"expiration_date":"2023-01-30","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0000899243-22-025827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924322025827/doc4.xml","form_type":"4"}},{"id":2210179,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-07-08T21:20:19.000Z","date":"2022-07-07","kind":"sale","acquired":false,"shares":55111,"price":26.2551,"value":1446944.8161,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2022, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $26.21 to $26.41. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2483107,"source":{"system":"sec-edgar","filing":"0000899243-22-025827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924322025827/doc4.xml","form_type":"4"}},{"id":2210178,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-07-08T21:20:19.000Z","date":"2022-07-06","kind":"sale","acquired":false,"shares":279908,"price":26.2658,"value":7352007.5464,"ownership":{"direct":false,"nature":"Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2022, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $26.21 to $26.65. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":2538218,"source":{"system":"sec-edgar","filing":"0000899243-22-025827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924322025827/doc4.xml","form_type":"4"}},{"id":2210177,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-07-08T21:20:19.000Z","date":"2022-07-06","kind":"tax_withholding","acquired":false,"shares":451189,"price":26.21,"value":11825663.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on July 6, 2022. The options subject to the net exercise were to expire on January 30, 2023."}],"balance_after":348811,"source":{"system":"sec-edgar","filing":"0000899243-22-025827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924322025827/doc4.xml","form_type":"4"}},{"id":2210176,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-07-08T21:20:19.000Z","date":"2022-07-06","kind":"exercise","acquired":true,"shares":800000,"price":2.08,"value":1664000.0,"ownership":{"direct":true},"balance_after":800000,"source":{"system":"sec-edgar","filing":"0000899243-22-025827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924322025827/doc4.xml","form_type":"4"}},{"id":2402462,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-11T23:50:14.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 2, 2022, so that the total number of shares subject to this option becomes fully vested and exercisable on February 2, 2026."}],"balance_after":500000,"derivative":{"exercise_price":19.26,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000899243-22-005945","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924322005945/doc4.xml","form_type":"4"}},{"id":2875110,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-08T22:19:05.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 5, 2021, so that the total number of shares subject to this option becomes fully vested and exercisable on February 5, 2025."}],"balance_after":500000,"derivative":{"exercise_price":29.41,"expiration_date":"2031-02-04","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000899243-21-005187","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924321005187/doc4.xml","form_type":"4"}},{"id":2896192,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-27T02:33:25.000Z","date":"2021-01-22","kind":"exercise","acquired":false,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":4.42,"expiration_date":"2021-05-19","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0000899243-21-003420","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924321003420/doc4.xml","form_type":"4"}},{"id":2896191,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-27T02:33:25.000Z","date":"2021-01-22","kind":"tax_withholding","acquired":false,"shares":481088,"price":28.06,"value":13499329.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on January 22, 2021.  The options subject to the net exercise were to expire on May 19, 2021."}],"balance_after":2818126,"source":{"system":"sec-edgar","filing":"0000899243-21-003420","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924321003420/doc4.xml","form_type":"4"}},{"id":2896190,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-27T02:33:25.000Z","date":"2021-01-22","kind":"exercise","acquired":true,"shares":800000,"price":4.42,"value":3536000.0,"ownership":{"direct":true},"balance_after":3299214,"source":{"system":"sec-edgar","filing":"0000899243-21-003420","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924321003420/doc4.xml","form_type":"4"}},{"id":3241925,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-28T23:54:01.000Z","date":"2020-02-26","kind":"disposition_to_issuer","acquired":false,"shares":20338,"price":13.54,"value":275376.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold so the Reporting Person could satisfy his remaining tax liability arising from a net (cashless) exercise of stock options that occurred in 2019. The date of the net exercise was March 20, 2019.  The options subject to the net exercise were to expire on March 26, 2019."}],"balance_after":2499214,"source":{"system":"sec-edgar","filing":"0000899243-20-006342","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924320006342/doc4.xml","form_type":"4"}},{"id":3280258,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-11T22:13:23.000Z","date":"2020-02-07","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 7, 2020, so that the total number of shares subject to this option becomes fully vested and exercisable on February 7, 2024."}],"balance_after":500000,"derivative":{"exercise_price":13.56,"expiration_date":"2030-02-06","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000899243-20-004044","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924320004044/doc4.xml","form_type":"4"}},{"id":3583531,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-21T19:01:22.000Z","date":"2019-03-20","kind":"exercise","acquired":false,"shares":782885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.19,"expiration_date":"2019-03-26","underlying":"Common Stock","underlying_shares":782885},"source":{"system":"sec-edgar","filing":"0000899243-19-008664","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924319008664/doc4.xml","form_type":"4"}},{"id":3583530,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-03-21T19:01:22.000Z","date":"2019-03-20","kind":"tax_withholding","acquired":false,"shares":427528,"price":11.93,"value":5100409.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were withheld at the election of the Reporting Person as payment for the purchased shares and to satisfy tax withholding obligations in connection with the purchase of the shares."}],"balance_after":2519552,"source":{"system":"sec-edgar","filing":"0000899243-19-008664","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924319008664/doc4.xml","form_type":"4"}},{"id":3583529,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-03-21T19:01:22.000Z","date":"2019-03-20","kind":"exercise","acquired":true,"shares":782885,"price":1.19,"value":931633.15,"ownership":{"direct":true},"balance_after":2947080,"source":{"system":"sec-edgar","filing":"0000899243-19-008664","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924319008664/doc4.xml","form_type":"4"}},{"id":3663883,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-13T02:41:59.000Z","date":"2018-12-12","kind":"exercise","acquired":false,"shares":217115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The transactions described herein were originally reported on a Form 4 filed on December 14, 2018.  This Form 4 is hereby being amended to correct the stock option exercise date and it does not describe any additional transactions."}],"balance_after":282885,"derivative":{"exercise_price":1.19,"expiration_date":"2019-03-26","underlying":"Common Stock","underlying_shares":217115},"source":{"system":"sec-edgar","filing":"0000899243-19-003383","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924319003383/doc4a.xml","form_type":"4/A","original_submission_date":"2018-12-14"}},{"id":3663882,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-02-13T02:41:59.000Z","date":"2018-12-12","kind":"sale","acquired":false,"shares":217115,"price":19.0061,"value":4126509.4015,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price for the entire number of shares sold.  The actual sale prices range from $18.75 to $19.48 per share.  Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request."}],"balance_after":2164195,"source":{"system":"sec-edgar","filing":"0000899243-19-003383","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924319003383/doc4a.xml","form_type":"4/A","original_submission_date":"2018-12-14"}},{"id":3663881,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-02-13T02:41:59.000Z","date":"2018-12-12","kind":"exercise","acquired":true,"shares":217115,"price":1.19,"value":258366.85,"ownership":{"direct":true},"balance_after":2381310,"source":{"system":"sec-edgar","filing":"0000899243-19-003383","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924319003383/doc4a.xml","form_type":"4/A","original_submission_date":"2018-12-14"}},{"id":3663862,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-13T02:38:10.000Z","date":"2019-02-08","kind":"grant","acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 8, 2019, so that the total number of shares subject to this option becomes fully vested and exercisable on February 8, 2023."}],"balance_after":475000,"derivative":{"exercise_price":11.35,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0000899243-19-003380","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924319003380/doc4.xml","form_type":"4"}},{"id":3731161,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-15T00:50:02.000Z","date":"2018-12-12","kind":"exercise","acquired":false,"shares":217115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":282885,"derivative":{"exercise_price":1.19,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":217115},"source":{"system":"sec-edgar","filing":"0000899243-18-031128","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924318031128/doc4.xml","form_type":"4"}},{"id":3731160,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-12-15T00:50:02.000Z","date":"2018-12-12","kind":"sale","acquired":false,"shares":217115,"price":19.0061,"value":4126509.4015,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price for the entire number of shares sold.  The actual sale prices range from $18.75 to $19.48 per share.  Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request."}],"balance_after":2164195,"source":{"system":"sec-edgar","filing":"0000899243-18-031128","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924318031128/doc4.xml","form_type":"4"}},{"id":3731159,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-12-15T00:50:02.000Z","date":"2018-12-12","kind":"exercise","acquired":true,"shares":217115,"price":1.19,"value":258366.85,"ownership":{"direct":true},"balance_after":2381310,"source":{"system":"sec-edgar","filing":"0000899243-18-031128","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924318031128/doc4.xml","form_type":"4"}},{"id":4068951,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-10T01:15:19.000Z","date":"2018-02-07","kind":"grant","acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 7, 2018, so that the total number of shares subject to this option becomes fully vested and exercisable on February 7, 2022."}],"balance_after":475000,"derivative":{"exercise_price":16.52,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0000899243-18-003471","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924318003471/doc4.xml","form_type":"4"}},{"id":4450414,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-14T23:04:22.000Z","date":"2017-02-10","kind":"grant","acquired":true,"shares":550000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 10, 2017, so that the total number of shares subject to this option becomes fully vested and exercisable on February 10, 2021."}],"balance_after":550000,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":550000},"source":{"system":"sec-edgar","filing":"0000899243-17-004044","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924317004044/doc4.xml","form_type":"4"}},{"id":4558642,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-15T00:43:04.000Z","date":"2016-11-11","kind":"exercise","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.5,"expiration_date":"2017-04-16","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-16-033400","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924316033400/doc4.xml","form_type":"4"}},{"id":4558641,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-15T00:43:04.000Z","date":"2016-11-10","kind":"exercise","acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable."}],"balance_after":200000,"derivative":{"exercise_price":1.5,"expiration_date":"2017-04-16","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000899243-16-033400","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924316033400/doc4.xml","form_type":"4"}},{"id":4558640,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2016-11-15T00:43:04.000Z","date":"2016-11-11","kind":"sale","acquired":false,"shares":200000,"price":9.1015,"value":1820300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold.  The actual sale prices range from $8.91 to $9.36 per share.  Detailed information on the exact number of shares sold at each sale price can be obtained upon request."}],"balance_after":2164195,"source":{"system":"sec-edgar","filing":"0000899243-16-033400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924316033400/doc4.xml","form_type":"4"}},{"id":4558639,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2016-11-15T00:43:04.000Z","date":"2016-11-11","kind":"exercise","acquired":true,"shares":200000,"price":1.5,"value":300000.0,"ownership":{"direct":true},"balance_after":2364195,"source":{"system":"sec-edgar","filing":"0000899243-16-033400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924316033400/doc4.xml","form_type":"4"}},{"id":4558638,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2016-11-15T00:43:04.000Z","date":"2016-11-10","kind":"sale","acquired":false,"shares":300000,"price":8.9015,"value":2670450.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price for the entire number of shares sold.  The actual sale prices range from $8.86 to $9.039 per share.  Detailed information on the exact number of shares sold at each sale price can be obtained upon request."}],"balance_after":2164195,"source":{"system":"sec-edgar","filing":"0000899243-16-033400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924316033400/doc4.xml","form_type":"4"}},{"id":4558637,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2016-11-15T00:43:04.000Z","date":"2016-11-10","kind":"exercise","acquired":true,"shares":300000,"price":1.5,"value":450000.0,"ownership":{"direct":true},"balance_after":2464195,"source":{"system":"sec-edgar","filing":"0000899243-16-033400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924316033400/doc4.xml","form_type":"4"}},{"id":4562639,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-10T01:29:28.000Z","date":"2016-11-07","kind":"exercise","acquired":false,"shares":406467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable."}],"balance_after":500000,"derivative":{"exercise_price":1.5,"expiration_date":"2017-04-16","underlying":"Common Stock","underlying_shares":406467},"source":{"system":"sec-edgar","filing":"0000899243-16-033097","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924316033097/doc4.xml","form_type":"4"}},{"id":4562638,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-10T01:29:28.000Z","date":"2016-11-07","kind":"exercise","acquired":false,"shares":93533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable."}],"balance_after":906467,"derivative":{"exercise_price":1.5,"expiration_date":"2017-04-16","underlying":"Common Stock","underlying_shares":93533},"source":{"system":"sec-edgar","filing":"0000899243-16-033097","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924316033097/doc4.xml","form_type":"4"}},{"id":4562637,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2016-11-10T01:29:28.000Z","date":"2016-11-07","kind":"sale","acquired":false,"shares":406467,"price":8.3244,"value":3383593.8948,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold.  The actual sale prices range from $8.27 to $8.375 per share.  Detailed information on the exact number of shares sold at each sale price can be obtained upon request."}],"balance_after":2164195,"source":{"system":"sec-edgar","filing":"0000899243-16-033097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924316033097/doc4.xml","form_type":"4"}},{"id":4562636,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2016-11-10T01:29:28.000Z","date":"2016-11-07","kind":"exercise","acquired":true,"shares":406467,"price":1.5,"value":609700.5,"ownership":{"direct":true},"balance_after":2570662,"source":{"system":"sec-edgar","filing":"0000899243-16-033097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924316033097/doc4.xml","form_type":"4"}},{"id":4562635,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2016-11-10T01:29:28.000Z","date":"2016-11-07","kind":"sale","acquired":false,"shares":93533,"price":8.2212,"value":768953.4996,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price for the entire number of shares sold.  The actual sale prices range from $8.22 to $8.24 per share.  Detailed information on the exact number of shares sold at each sale price can be obtained upon request."}],"balance_after":2164195,"source":{"system":"sec-edgar","filing":"0000899243-16-033097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924316033097/doc4.xml","form_type":"4"}},{"id":4562634,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":42541,"kind":"person","name":"BELANOFF JOSEPH K","position":1,"cik":"0001286199","reported_name":"BELANOFF JOSEPH K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2016-11-10T01:29:28.000Z","date":"2016-11-07","kind":"exercise","acquired":true,"shares":93533,"price":1.5,"value":140299.5,"ownership":{"direct":true},"balance_after":2257728,"source":{"system":"sec-edgar","filing":"0000899243-16-033097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924316033097/doc4.xml","form_type":"4"}}]}